Active Ingredient: DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM
Proprietary Name: HYPAQUE-M,75%
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 50%;25%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N010220
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: GE HEALTHCARE
Marketing Status:
Discontinued
Patent and Exclusivity Information